David Dickerson, MD, chair of the ASA Committee on Pain Medicine, discusses suggested changes and recommendations to the proposed clinical practice guidelines for prescribing opioids that were recently issued by the CDC.
The Pfizer-BioNTech COVID-19 vaccine contributed to substantial public health impact and vaccine-preventable cost savings in the first year of its US rollout.
Researchers sought to examine the demographic and clinical characteristics of patients who were infected with COVID-19 and developed PASC.
It is a number many Americans have grimly expected but may still find hard to comprehend: More than 1 million Americans have died from COVID-19.
While food insecurity is a leading public health issue, research shows that nutrition security may be a better target for disease prevention strategies.
Evidence of quality control problems was hidden by a company contracted by the US government to produce hundreds of millions of COVID-19 vaccine doses, a new House committee report shows.
An antiviral drug used to treat high-risk COVID-19 patients may also benefit patients with long COVID, researchers say.
The American College of Cardiology has published guidelines for managing adult patients with cardiovascular sequelae after COVID-19 infection.
Coronavirus-like particles (CoVLP), which are produced in plants, combined with an adjuvant (Adjuvant System 03 [AS03]) forms a candidate vaccine that is effective for preventing COVID-19.
Adult vaccination rates and socioeconomic factors impacted children’s mental health during the first year of the COVID-19 pandemic.